Knowledge hub

Knowledge hub

News

News

Ardigen Strengthens Advisory Board with Extrepreneur and Computational Biologist Dr. Guy Cavet

Happy Easter holiday
Dr. Michał Warchoł has joined the company’s Board of Management as its 4th member
Conferences – where can you find us in February?
Holiday Wishes
Ardigen and The BioCollective partner to detect early signs of Parkinson’s Disease for better diagnosis and treatment.
5 years for precision medicine – Ardigen’s anniversary
AI aided design of epitope-based vaccine for the induction of cellular immune responses against SARS-CoV-2
Agnieszka Blum, PhD MD, joins Ardigen as the General Director of Immunology
News

Ardigen has received funding to accelerate its AI-driven TCR discovery platform for novel cell therapies

Ardigen enters into research collaboration with CVC to apply Artificial Intelligence for identification of T-cell targets – press release
AACR poster -2
Microbial signatures of response to anti-PD1 therapy in metastatic melanoma patients
AACR poster – 1
Accounting for immune escape mechanisms in personalized and shared neoantigen cancer vaccine design
Selvita and Ardigen will receive funding for the development of an AI-based high-content screening platform
We are ready to support your efforts in the fight against COVID-19
The microbiome as a potential weapon against novel coronavirus SARS-CoV-2
Ardigen at AI Powered Drug Discovery and Manufacturing Conference
A new publication about molecule property prediction: Molecule Attention Transformer
  • Services
  • Technology
Social Media
United States

611 Gateway Boulevard
South San Francisco, CA 94080
USA
tel.+1 628 200 09 14

One Broadway, 14th Floor
Cambridge, MA 02142
USA
tel.+1 628 200 09 14

European Union

Sternbacha 1
30-394 Kraków
Poland
tel.+48 12 340 94 94